News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
William M. McClements Joins Merrimack Pharmaceuticals Inc. as Senior Vice President of Corporate Operations
July 10, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CAMBRIDGE, Mass., July 9, 2012 (GLOBE NEWSWIRE) -- William M. McClements, a former executive at the Monitor Group, has joined Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) as Senior Vice President of Corporate Operations.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Podcast
COVID-19 Vaccine Overhaul, Rocket Grounded, ‘One Tough Hombre’ on MFN
May 28, 2025
·
2 min read
·
Heather McKenzie
Pain
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy
May 27, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Boundless Laying Off 33% of Staff
May 27, 2025
·
213 min read
·
BioSpace Editorial Staff
Funding
Novo-Backed GlycoEra Raises $130M To Advance Protein Degraders for Precision Immunology
May 27, 2025
·
2 min read
·
Tristan Manalac